{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:14:01Z","timestamp":1790270041800,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":60,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642006623","type":"print"},{"value":"9783642006630","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-3-642-00663-0_5","type":"book-chapter","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T16:31:14Z","timestamp":1257265874000},"page":"111-130","source":"Crossref","is-referenced-by-count":76,"title":["Mechanisms of Drug-Induced Nephrotoxicity"],"prefix":"10.1007","author":[{"given":"Thomas D.","family":"Nolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,21]]},"reference":[{"key":"5_CR1_5","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1681\/ASN.2006030225","volume":"17","author":"M Albaqumi","year":"2006","unstructured":"Albaqumi M, Soos TJ, Barisoni L, Nelson PJ (2006) Collapsing glomerulopathy. J Am Soc Nephrol 17:2854\u20132863","journal-title":"J Am Soc Nephrol"},{"key":"5_CR2_5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1056\/NEJMcp050801","volume":"354","author":"BJ Barrett","year":"2006","unstructured":"Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379\u2013386","journal-title":"N Engl J Med"},{"key":"5_CR3_5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.ajkd.2005.03.024","volume":"46","author":"GL Braden","year":"2005","unstructured":"Braden GL, O'Shea MH, Mulhern JG (2005) Tubulointerstitial diseases. Am J Kidney Dis 46:560\u2013572","journal-title":"Am J Kidney Dis"},{"key":"5_CR4_5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/01926230290166760","volume":"30","author":"AE Brix","year":"2002","unstructured":"Brix AE (2002) Renal papillary necrosis. Toxicol Pathol 30:672\u2013674","journal-title":"Toxicol Pathol"},{"key":"5_CR5_5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","volume":"23","author":"EA Burdmann","year":"2003","unstructured":"Burdmann EA, Andoh TF, Yu L, Bennett WM (2003) Cyclosporine nephrotoxicity. Semin Nephrol 23:465\u2013476","journal-title":"Semin Nephrol"},{"key":"5_CR6_5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","volume":"43","author":"HK Choi","year":"2000","unstructured":"Choi HK, Merkel PA, Walker AM, Niles JL (2000) Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43:405\u2013413","journal-title":"Arthritis Rheum"},{"key":"5_CR7_5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncpneph0076","volume":"2","author":"D Choudhury","year":"2006","unstructured":"Choudhury D, Ahmed Z (2006) Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2:80\u201391","journal-title":"Nat Clin Pract Nephrol"},{"key":"5_CR8_5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00075198-200112000-00002","volume":"7","author":"S Costa","year":"2001","unstructured":"Costa S, Nucci M (2001) Can we decrease amphotericin nephrotoxicity? Curr Opin Crit Care 7:379\u2013383","journal-title":"Curr Opin Crit Care"},{"key":"5_CR9_5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200326010-00004","volume":"26","author":"JP Cosyns","year":"2003","unstructured":"Cosyns JP (2003) Aristolochic acid and \u2018Chinese herbs nephropathy': a review of the evidence to date. Drug Saf 26:33\u201348","journal-title":"Drug Saf"},{"key":"5_CR10_5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-002-0024-y","volume":"4","author":"ML Cuellar","year":"2002","unstructured":"Cuellar ML (2002) Drug-induced vasculitis. Curr Rheumatol Rep 4:55\u201359","journal-title":"Curr Rheumatol Rep"},{"key":"5_CR11_5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/snep.2003.50012","volume":"23","author":"V D'agati","year":"2003","unstructured":"D'agati V (2003) Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23:117\u2013134","journal-title":"Semin Nephrol"},{"key":"5_CR12_5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00003495-200464030-00003","volume":"64","author":"M Daudon","year":"2004","unstructured":"Daudon M, Jungers P (2004) Drug-induced renal calculi: epidemiology, prevention and management. Drugs 64:245\u2013275","journal-title":"Drugs"},{"key":"5_CR13_5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1056\/NEJM199802123380707","volume":"338","author":"ME Broe De","year":"1998","unstructured":"De Broe ME, Elseviers MM (1998) Analgesic nephropathy. N Engl J Med 338:446\u2013452","journal-title":"N Engl J Med"},{"key":"5_CR14_5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","volume":"35","author":"AM Mattos de","year":"2000","unstructured":"de Mattos AM, Olyaei AJ, Bennett WM (2000) Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35:333\u2013346","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"5_CR15_5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","volume":"49","author":"G Deray","year":"2002","unstructured":"Deray G (2002) Amphotericin B nephrotoxicity. J Antimicrob Chemother 49(Suppl 1):37\u201341","journal-title":"J Antimicrob Chemother"},{"key":"5_CR16_5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","volume":"8","author":"JS Dlott","year":"2004","unstructured":"Dlott JS, Danielson CF, Blue-Hnidy DE, McCarthy LJ (2004) Drug-induced thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome: a concise review. Ther Apher Dial 8:102\u2013111","journal-title":"Ther Apher Dial"},{"key":"5_CR17_5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1525-139X.1996.tb00304.x","volume":"9","author":"TA Elasy","year":"1996","unstructured":"Elasy TA, Anderson RJ (1996) Changing demography of acute renal failure. Semin Dial 9:438\u2013443","journal-title":"Semin Dial"},{"key":"5_CR18_5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1592\/phco.24.6.697.34731","volume":"24","author":"BJ Epstein","year":"2004","unstructured":"Epstein BJ (2004) Elevations in serum creatinine concentration: concerning or reassuring? Pharmacotherapy 24:697\u2013702","journal-title":"Pharmacotherapy"},{"key":"5_CR19_5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bmj.322.7286.579","volume":"322","author":"U Eriksson","year":"2001","unstructured":"Eriksson U, Seifert B, Schaffner A (2001) Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ 322:579\u2013582","journal-title":"BMJ"},{"key":"5_CR20_5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","volume":"12","author":"V Fanos","year":"2000","unstructured":"Fanos V, Cataldi L (2000) Amphotericin B-induced nephrotoxicity: a review. J Chemother 12:463\u2013470","journal-title":"J Chemother"},{"key":"5_CR21_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5858\/2006-130-101-RFANAW","volume":"130","author":"G Gonlusen","year":"2006","unstructured":"Gonlusen G, Akgun H, Ertan A, Olivero J, Truong LD (2006) Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 130:101\u2013106","journal-title":"Arch Pathol Lab Med"},{"key":"5_CR22_5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a010234","volume":"151","author":"MR Griffin","year":"2000","unstructured":"Griffin MR, Yared A, Ray WA (2000) Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 151:488\u2013496","journal-title":"Am J Epidemiol"},{"key":"5_CR23_5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14656566.4.6.889","volume":"4","author":"JT Hartmann","year":"2003","unstructured":"Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889\u2013901","journal-title":"Expert Opin Pharmacother"},{"key":"5_CR24_5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","volume":"45","author":"H Izzedine","year":"2005","unstructured":"Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:804\u2013817","journal-title":"Am J Kidney Dis"},{"key":"5_CR25_5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/14740338.5.1.95","volume":"5","author":"H Izzedine","year":"2006","unstructured":"Izzedine H, Launay-Vacher V, Bourry E, Brocheriou I, Karie S, Deray G (2006) Drug-induced glomerulopathies. Expert Opin Drug Saf 5:95\u2013106","journal-title":"Expert Opin Drug Saf"},{"key":"5_CR26_5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2215\/CJN.00300106","volume":"1","author":"JA Jaffe","year":"2006","unstructured":"Jaffe JA, Kimmel PL (2006) Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin J Am Soc Nephrol 1:655\u2013667","journal-title":"Clin J Am Soc Nephrol"},{"key":"5_CR27_5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Saf 24:19\u201338","journal-title":"Drug Saf"},{"key":"5_CR28_5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ncpneph0225","volume":"2","author":"P Liptak","year":"2006","unstructured":"Liptak P, Ivanyi B (2006) Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2:398\u2013404","journal-title":"Nat Clin Pract Nephrol"},{"key":"5_CR29_5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jacc.2004.06.075","volume":"44","author":"M Maeder","year":"2004","unstructured":"Maeder M, Klein M, Fehr T, Rickli H (2004) Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 44:1763\u20131771","journal-title":"J Am Coll Cardiol"},{"key":"5_CR30_5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","volume":"351","author":"GS Markowitz","year":"2005","unstructured":"Markowitz GS, Perazella MA (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 351:31\u201347","journal-title":"Clin Chim Acta"},{"key":"5_CR31_5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","volume":"11","author":"GS Markowitz","year":"2000","unstructured":"Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439\u20131448","journal-title":"J Am Soc Nephrol"},{"key":"5_CR32_5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD (2001) Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12:1164\u20131172","journal-title":"J Am Soc Nephrol"},{"key":"5_CR33_5","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1681\/ASN.2005050496","volume":"16","author":"GS Markowitz","year":"2005","unstructured":"Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD (2005) Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 16:3389\u20133396","journal-title":"J Am Soc Nephrol"},{"key":"5_CR34_5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/ajkd.1998.v32.pm9740154","volume":"32","author":"L Maurice-Estepa","year":"1998","unstructured":"Maurice-Estepa L, Daudon M, Katlama C, Jouanneau C, Sazdovitch V, Lacour B, Beaufils H (1998) Identification of crystals in kidneys of AIDS patients treated with foscarnet. Am J Kidney Dis 32:392\u2013400","journal-title":"Am J Kidney Dis"},{"key":"5_CR35_5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003\u20131012","journal-title":"Antimicrob Agents Chemother"},{"key":"5_CR36_5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.V111177","volume":"11","author":"SW Murphy","year":"2000","unstructured":"Murphy SW, Barrett BJ, Parfrey PS (2000) Contrast nephropathy. J Am Soc Nephrol 11:177\u2013182","journal-title":"J Am Soc Nephrol"},{"key":"5_CR37_5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2133\/dmpk.19.159","volume":"19","author":"J Nagai","year":"2004","unstructured":"Nagai J, Takano M (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19:159\u2013170","journal-title":"Drug Metab Pharmacokinet"},{"key":"5_CR38_5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","volume":"39","author":"K Nash","year":"2002","unstructured":"Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930\u2013936","journal-title":"Am J Kidney Dis"},{"key":"5_CR39_5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931\u2013940","journal-title":"N Engl J Med"},{"key":"5_CR40_5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","volume":"7","author":"AJ Olyaei","year":"2001","unstructured":"Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7:384\u2013389","journal-title":"Curr Opin Crit Care"},{"key":"5_CR41_5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H, Tishler M, Shoenfeld Y (2004) Intravenous immunoglobulin and the kidney\u2013a two-edged sword. Semin Arthritis Rheum 34:593\u2013601","journal-title":"Semin Arthritis Rheum"},{"key":"5_CR42_5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","volume":"106","author":"MA Perazella","year":"1999","unstructured":"Perazella MA (1999) Crystal-induced acute renal failure. Am J Med 106:459\u2013465","journal-title":"Am J Med"},{"key":"5_CR43_5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","volume":"325","author":"MA Perazella","year":"2003","unstructured":"Perazella MA (2003) Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 325:349\u2013362","journal-title":"Am J Med Sci"},{"key":"5_CR44_5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1517\/14740338.4.4.689","volume":"4","author":"MA Perazella","year":"2005","unstructured":"Perazella MA (2005) Drug-induced nephropathy: an update. Expert Opin Drug Saf 4:689\u2013706","journal-title":"Expert Opin Drug Saf"},{"key":"5_CR45_5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2165\/00002018-200124070-00002","volume":"24","author":"R Pisoni","year":"2001","unstructured":"Pisoni R, Ruggenenti P, Remuzzi G (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf 24:491\u2013501","journal-title":"Drug Saf"},{"key":"5_CR46_5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1046\/j.1523-1755.2003.00096.x","volume":"64","author":"C Presne","year":"2003","unstructured":"Presne C, Fakhouri F, Noel LH, Stengel B, Even C, Kreis H, Mignon F, Grunfeld JP (2003) Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int 64:585\u2013592","journal-title":"Kidney Int"},{"key":"5_CR47_5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/12.1.81","volume":"12","author":"F Reginster","year":"1997","unstructured":"Reginster F, Jadoul M, van Ypersele DS (1997) Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant 12:81\u201386","journal-title":"Nephrol Dial Transplant"},{"key":"5_CR48_5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60:804\u2013817","journal-title":"Kidney Int"},{"key":"5_CR49_5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3949\/ccjm.73.1.75","volume":"73","author":"MR Rudnick","year":"2006","unstructured":"Rudnick MR, Kesselheim A, Goldfarb S (2006) Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 73:75\u201377","journal-title":"Cleve Clin J Med"},{"key":"5_CR50_5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/01.ccx.0000184300.68383.95","volume":"11","author":"M Schetz","year":"2005","unstructured":"Schetz M, Dasta J, Goldstein S, Golper T (2005) Drug-induced acute kidney injury. Curr Opin Crit Care 11:555\u2013565","journal-title":"Curr Opin Crit Care"},{"issue":"Suppl 2","key":"5_CR51_5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/01926230490457530","volume":"32","author":"FG Silva","year":"2004","unstructured":"Silva FG (2004) Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans. Toxicol Pathol 32(Suppl 2):71\u201384","journal-title":"Toxicol Pathol"},{"key":"5_CR52_5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00019053-199814040-00005","volume":"14","author":"RL Slaughter","year":"1998","unstructured":"Slaughter RL, Cappelletty DM (1998) Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring. Pharmacoeconomics 14:385\u2013394","journal-title":"Pharmacoeconomics"},{"key":"5_CR53_5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1592\/phco.21.5.443.34490","volume":"21","author":"DS Streetman","year":"2001","unstructured":"Streetman DS, Nafziger AN, Destache CJ, Bertino AS Jr (2001) Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy 21:443\u2013451","journal-title":"Pharmacotherapy"},{"key":"5_CR54_5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000086055","volume":"148","author":"T Taguchi","year":"2005","unstructured":"Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107\u2013121","journal-title":"Contrib Nephrol"},{"key":"5_CR55_5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1345\/aph.1A124","volume":"36","author":"SM Holder ten","year":"2002","unstructured":"ten Holder SM, Joy MS, Falk RJ (2002) Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 36:130\u2013147","journal-title":"Ann Pharmacother"},{"key":"5_CR56_5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJM199605303342207","volume":"334","author":"R Thadhani","year":"1996","unstructured":"Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334:1448\u20131460","journal-title":"N Engl J Med"},{"key":"5_CR57_5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V1181553","volume":"11","author":"R Vanholder","year":"2000","unstructured":"Vanholder R, Sever MS, Erek E, Lameire N (2000) Rhabdomyolysis. J Am Soc Nephrol 11:1553\u20131561","journal-title":"J Am Soc Nephrol"},{"key":"5_CR58_5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1051-0443(07)61394-3","volume":"12","author":"MM Waybill","year":"2001","unstructured":"Waybill MM, Waybill PN (2001) Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3\u20139","journal-title":"J Vasc Interv Radiol"},{"key":"5_CR59_5","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106:13S\u201324S","journal-title":"Am J Med"},{"key":"5_CR60_5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0895-7061(98)00117-4","volume":"11","author":"A Wynckel","year":"1998","unstructured":"Wynckel A, Ebikili B, Melin JP, Randoux C, Lavaud S, Chanard J (1998) Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am J Hypertens 11:1080\u20131086","journal-title":"Am J Hypertens"}],"container-title":["Handbook of Experimental Pharmacology","Adverse Drug Reactions"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-00663-0_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T09:10:34Z","timestamp":1634116234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-00663-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,21]]},"ISBN":["9783642006623","9783642006630"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-00663-0_5","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,21]]}}}